Antiviral drugs: Inside the envelope.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 12, p. 1000, doi. 10.1038/nrd1587
- By:
- Publication type:
- Article
Works matching IS 14741776 AND DT 2004 AND VI 3 AND IP 12
Results: 19
1
2
Pharmaceutical patent challenges--time for reassessment?
- Published in:
- 2004
- By:
- Publication type:
- review
3
In brief.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 12, p. 1000, doi. 10.1038/nrd1590
- Publication type:
- Article
4
Novel initiative seeks genetic causes of diabetes risk.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 12, p. 987, doi. 10.1038/nrd1594
- By:
- Publication type:
- Article
5
Cyclodextrin-based pharmaceutics: past, present and future.
- Published in:
- 2004
- By:
- Publication type:
- journal article
6
Challenges in bringing the bench to bedside in drug development for sle.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 12, p. 1036, doi. 10.1038/nrd1577
- By:
- Publication type:
- Article
7
Making protein interactions druggable: targeting PDZ domains.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 12, p. 1047, doi. 10.1038/nrd1578
- By:
- Publication type:
- Article
8
Strategies to overcome resistance to targeted protein kinase inhibitors.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 12, p. 1001, doi. 10.1038/nrd1579
- By:
- Publication type:
- Article
9
Development of TGF-ßsignalling inhibitors for cancer therapy.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 12, p. 1011, doi. 10.1038/nrd1580
- By:
- Publication type:
- Article
10
From the analyst's couch: Targeting protein kinases.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 12, p. 993, doi. 10.1038/nrd1600
- By:
- Publication type:
- Article
11
Neurodegenerative disease: Body-building for small molecules.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 12, p. 998, doi. 10.1038/nrd1585
- By:
- Publication type:
- Article
12
Inflammation: Nicotine goes into septic shock.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 12, p. 998, doi. 10.1038/nrd1586
- By:
- Publication type:
- Article
13
Bevacizumab.
- Published in:
- 2004
- By:
- Publication type:
- journal article
14
RNA interference: Silencing the sceptics.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 12, p. 997, doi. 10.1038/nrd1588
- By:
- Publication type:
- Article
15
Keeping an open mind.
- Published in:
- 2004
- Publication type:
- Editorial
16
News in Brief.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 12, p. 988, doi. 10.1038/nrd1597
- Publication type:
- Article
17
Kinases: Making gains on glioma.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 12, p. 999, doi. 10.1038/nrd1599
- By:
- Publication type:
- Article
18
Reviews and comment from the nature publishing group.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 12, p. 1063, doi. 10.1038/nrd1602
- Publication type:
- Article
19
Rebranding to recruit.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 12, p. 1065, doi. 10.1038/nrd1604
- By:
- Publication type:
- Article